A Case of Refractory Eosinophilic Gastrointestinal Disease Successfully Treated With Dupilumab-Reference-Cited by-同舟云学术

A Case of Refractory Eosinophilic Gastrointestinal Disease Successfully Treated With Dupilumab

Published:2023-11 Issue:11 Volume:10 Page:e01187
ISSN:2326-3253
Container-title:ACG Case Reports Journal
language:en
Short-container-title:ACG Case Rep J

Author:

Arnold Casey¹,Johnson Jeptha¹,Harris Nieka¹,Sadowski Brett²,Banks Taylor¹,Bush Allison¹

Affiliation:

1. Naval Medical Center Portsmouth, Portsmouth, VA

2. Naval Medical Center San Diego, San Diego, CA

Abstract

ABSTRACT Eosinophilic infiltration of the gastrointestinal (GI) tract beyond the esophagus is a rare condition in adults with limited data on treatment. Current treatments with steroids and diet modifications have shown benefit, but when these treatments fall short, there is little research-driven guidance for further recommendations. We present a case of eosinophilic GI disease with extensive involvement of the GI tract successfully treated with dupilumab after failure of traditional treatment occurred.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference13 articles.

1. Consortium of eosinophilic gastrointestinal disease researchers (CEGIR). Increasing rates of diagnosis, substantial co-occurrence, and variable treatment patterns of eosinophilic gastritis, gastroenteritis, and colitis based on 10-year data across a multicenter consortium;Pesek;Am J Gastroenterol.,2019

2. Eosinophilic gastroenteritis: A state-of-the-art review;Zhang;J Gastroenterol Hepatol.,2017

3. Eosinophilic gastrointestinal disorders;Gonsalves;Clin Rev Allergy Immunol.,2019

4. Vedolizumab treatment may reduce steroid burden and improve histology in patients with eosinophilic gastroenteritis;Kim;Clin Gastroenterol Hepatol.,2018

5. Eosinophilic gastroenteritis-associated duodenal ulcer successfully treated with crushed budesonide;Kubo;Intern Med.,2020